Brincidofovir

CHEMBL203321 Phase 4 Onaylandı Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

561.7 g/mol

LogP

4.9

Phase

4

An oral antiviral medication used for the treatment of human smallpox disease caused by variola virus. It is a lipid conjugate of cidofovir that improves oral bioavailability while reducing kidney toxicity associated with cidofovir itself. It is considered a medical countermeasure for bioterrorism-related smallpox exposure.

Moleküler Ağırlık

561,7000 g/mol

LogP

4,90

TPSA

144,00 Å²

Lipinski RO5

Geçer

Terapötik Alanlar

Lymphoma

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Yapı

SVG PNG

Cite this structure

Embed this structure

SMILES

CCCCCCCCCCCCCCCCOCCCOP(=O)(O)CO[C@H](CO)Cn1ccc(N)nc1=O

InChI

InChI=1S/C27H52N3O7P/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-19-35-20-16-21-37-38(33,34)24-36-25(23-31)22-30-18-17-26(28)29-27(30)32/h17-18,25,31H,2-16,19-24H2,1H3,(H,33,34)(H2,28,29,32)/t25-/m0/s1

Molecular Formula

C27H52N3O7P

HBD / HBA

3 / 7

Döndürülebilir Bağlar

26

Ağır Atomlar

38

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Sıkça Sorulan Sorular

An oral antiviral medication used for the treatment of human smallpox disease caused by variola virus. It is a lipid conjugate of cidofovir that improves oral bioavailability while reducing kidney toxicity associated with cidofovir itself. It is considered a medical countermeasure for bioterrorism-related smallpox exposure.

Yes, Brincidofovir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL203321. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 483477. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Hasta dostu bilgi mi arıyorsunuz?

Brincidofovir PillFYI'da

Yapı

Hızlı Veriler

Formül: C27H52N3O7P
Eş Anlamlılar: 1

Dış Bağlantılar

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Tıbbi Sorumluluk Reddi

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.